Literature DB >> 14624565

A highly stable gadolinium complex with a fast, associative mechanism of water exchange.

Marlon K Thompson1, Mauro Botta, Gaëlle Nicolle, Lothar Helm, Silvio Aime, André E Merbach, Kenneth N Raymond.   

Abstract

The stability and water exchange dynamics of gadolinium (GdIII) complexes are critical characteristics that determine their effectiveness as contrast agents for magnetic resonance imaging (MRI). A new heteropodal GdIII chelate, [Gd-TREN-bis(6-Me-HOPO)-(TAM-TRI)(H2O)2] (Gd-2), is presented which is based on a hydroxypyridinate (HOPO)-terephthalamide (TAM) ligand design. Thermodynamic equilibrium constants for the acid-base properties and the GdIII complexation strength of TREN-bis(6-Me-HOPO)-(TAM-TRI) (2) were measured by potentiometric and spectrophotometric titration techniques, respectively. The pGd of 2 is 20.6 (pH 7.4, 25 degrees C, I = 0.1 M), indicating that Gd-2 is of more than sufficient thermodynamic stability for in vivo MRI applications. The water exchange rate of Gd-2 (kex = 5.3(+/-0.6) x 107 s-1) was determined by variable temperature 17O NMR and is in the fast exchange regime - ideal for MRI. Variable pressure 17O NMR was used to determine the volume of activation (DeltaV) of Gd-2. DeltaV for Gd-2 is -5 cm3 mol-1, indicative of an interchange associative (Ia) water exchange mechanism. The results reported herein are important as they provide insight into the factors influencing high stability and fast water exchange in the HOPO series of complexes, potentially future clinical contrast agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624565     DOI: 10.1021/ja037441d

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  11 in total

1.  Tuning the coordination number of hydroxypyridonate-based gadolinium complexes: implications for MRI contrast agents.

Authors:  Valérie C Pierre; Mauro Botta; Silvio Aime; Kenneth N Raymond
Journal:  J Am Chem Soc       Date:  2006-04-26       Impact factor: 15.419

2.  Strategies for the preparation of bifunctional gadolinium(III) chelators.

Authors:  Luca Frullano; Peter Caravan
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

3.  Toward the Design of MR Agents for Imaging β-Cell Function.

Authors:  Mark Woods; Shanrong Zhang; A Dean Sherry
Journal:  Curr Med Chem Immunol Endocr Metab Agents       Date:  2004-12

Review 4.  Lanthanide probes for bioresponsive imaging.

Authors:  Marie C Heffern; Lauren M Matosziuk; Thomas J Meade
Journal:  Chem Rev       Date:  2013-12-13       Impact factor: 60.622

5.  Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules.

Authors:  Valérie C Pierre; Mauro Botta; Silvio Aime; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2006-10-02       Impact factor: 5.165

6.  Multivalent, high-relaxivity MRI contrast agents using rigid cysteine-reactive gadolinium complexes.

Authors:  Praveena D Garimella; Ankona Datta; Dante W Romanini; Kenneth N Raymond; Matthew B Francis
Journal:  J Am Chem Soc       Date:  2011-08-26       Impact factor: 15.419

Review 7.  MR imaging probes: design and applications.

Authors:  Eszter Boros; Eric M Gale; Peter Caravan
Journal:  Dalton Trans       Date:  2015-03-21       Impact factor: 4.390

Review 8.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

Review 9.  The importance of water exchange rates in the design of responsive agents for MRI.

Authors:  A Dean Sherry; Yunkou Wu
Journal:  Curr Opin Chem Biol       Date:  2013-01-17       Impact factor: 8.822

Review 10.  Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.

Authors:  Ankona Datta; Kenneth N Raymond
Journal:  Acc Chem Res       Date:  2009-07-21       Impact factor: 22.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.